Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

MOC-carboetomidate induces hypnosis without adrenocortical suppression

Oct. 28, 2011

Trial confirms earlier results with PET imaging agent florbetaben (18F)

Oct. 28, 2011

Phase III data support safety of dextromethorphan hydrobromide/quinidine sulfate in MS

Oct. 28, 2011

New vaccine shows promise in several models of infection

Oct. 28, 2011

Phase II trial evaluates fingolimod in Japanese patients with MS

Oct. 27, 2011

Celiac disease candidate therapy completes proof-of-principle phase II study

Oct. 27, 2011

Influenza HA1-flagellin fusion vaccines well tolerated in healthy volunteers

Oct. 27, 2011

BF-200 ALA shows efficacy in treating actinic keratosis in advanced studies

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...